Hussman Strategic Advisors’s Edwards Lifesciences EW Stock Holding History

Hussman Strategic Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-150,000	Closed	-$6.03M	–	196
2016 Q3	$6.03M	Hold	150,000	–	–	0.99%	47
2016 Q2	$4.99M	Hold	150,000	–	–	0.76%	57
2016 Q1	$4.41M	Hold	150,000	–	–	0.58%	67
2015 Q4	$3.95M	Hold	150,000	–	–	0.56%	69
2015 Q3	$3.55M	Hold	150,000	–	–	0.45%	93
2015 Q2	$3.56M	Buy	+150,000	New	+$3.39M	0.41%	97

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Hussman Strategic Advisors's EW Position: Q4 2016 in Review

Hussman Strategic Advisors sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 150,000 shares — an estimated $6.03M sold.

Hussman Strategic Advisors first reported a position in EW in Q2 2015 and held it in 6 quarters. The position peaked at $6.03M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

Hussman Strategic Advisors reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
Hussman Strategic Advisors sold 150,000 Edwards Lifesciences shares in Q4 2016, an estimated $6.03M.
Hussman Strategic Advisors first reported a position in Edwards Lifesciences in Q2 2015 and held it in 6 quarters.
Hussman Strategic Advisors's Edwards Lifesciences position peaked at $6.03M in Q3 2016.
686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on Hussman Strategic Advisors's 13F filing for Q4 2016, filed 1 Feb 2017.